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Indigenous Health
FALLI NG MOR TA LITY RATES over
recent decades for stomach cancer, lung
cancer in men, cervical cancer and,
more recently, breast and colorectal
cancers are evidence of the effectiveness
of cancer pr vention and treatment for
most Australians.1 To what extent these
trends apply to Indigenous Australians
is uncertain, because until now studies
of Indigenous cancer mortality have
been for restricted periods of time, or
time trends have not been examined in
detail.2,3 This is the first detailed report
of long-term trends in Indigenous can-
cer mortality.
METHODS
Data collection
De-identified unit record data were
obtained from the Australian Bureau of
Statistics (ABS) for all deaths of North-
ern Territory (NT) residents registered
in Australia since 1977. From 1988,
Indigenous status was included in NT
death notification forms, and identifica-
tion of Indigenous deaths is estimated
by the ABS to be close to complete.4
For deaths before 1988, Indigenous sta-
tus was inferred from other information
in the death register by a previously
validated method.5 Data on deaths were
analysed by year of death, not year of
registration. An internally consistent
time-series of Indigenous population
estimates for the NT were used to cal-
culate mortality rates.5 Data on deaths
for the total Australian population and
population estimates were obtained
from the Australian Institute of Health
and Welfare.6
Cancer deaths
Cancer deaths in the NT Indigenous
population were compared with those in
the total Australian population for the
period 1991–2000. Cancer deaths were
compared for cancers arising at 18 dif-
ferent sites plus those with an unknown
primary site. Cancer mortality trends
for NT Indigenous people between
1977 and 2000 were examined for 11
cancer sites.
Cancers of the oropharynx (excluding
salivary glands), oesophagus, stomach,
anus, pancreas, larynx, lung, vulva,
penis, bladder, and renal parenchyma
and pelvis were grouped as smoking-
related cancers. Only a proportion of
deaths from each of these specific can-
cers is caused by smoking,7 but there is
insufficient information available for
Indigenous Australians to estimate, for
each site, the proportion of cancers
attributable to smoking over the 24-year
period reported here.
Statistical analysis
Statistical analysis was performed using
Stata.8 Analysis of mortality rate ratios
(for the NT Indigenous population
compared with the total Australian pop-
ulation) was performed using negative
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Design:  Comparison of cancer mortality rates of the NT Indigenous population with 
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in cancer mortality rates in the NT Indigenous population, 1977–2000.
Participants:  NT Indigenous and total Australian populations, 1977–2000.
Main outcome measures:  Cancer mortality rate ratios and percentage change 
in annual mortality rates.
Results:  The NT Indigenous cancer mortality rate was higher than the total Australian 
rate for cancers of the liver, lungs, uterus, cervix and thyroid, and, in younger people 
only, for cancers of the oropharynx, oesophagus and pancreas. NT Indigenous 
mortality rates were lower than the total Australian rates for renal cancers and 
melanoma and, in older people only, for cancers of the prostate and bowel. Differences 
between Indigenous and total Australian cancer mortality rates were more pronounced 
among those aged under 64 years for most cancers. NT Indigenous cancer mortality 
rates increased over the 24-year period for cancers of the oropharynx, pancreas and 
lung, all of which are smoking-related cancers.
Conclusions:  Cancer is an important and increasing health problem for Indigenous 
Australians. Cancers that affect Indigenous Australians to a greater extent than other 
Australians are largely preventable (eg, through smoking cessation, Pap smear 
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binomial regression,8 in preference to
Poisson regression, because of overdis-
persion of death data. Mortality rate
ratios were estimated in a model con-
taining age, square of age, sex and
indicator variables for the four combi-
nations of population group and age
above or below 65 years (ie, total Aus-
tralian population, 0–64 years; total
Australian population, 65 years and
over; NT Indigenous population 0–64
years and NT Indigenous population 65
years and over). The term for square of
age was included because mortality
rates did not increase uniformly with
age.
The cancer mortality time trends
were analysed using a negative binomial
regression model that included terms
for age, square of age, sex and year of
death. Time trends were reported as the
average annual and total percentage
increase between 1977 and 2000 for all
age-groups combined. The combined
male and female age- and sex-standard-
ised mortality rate was used to demon-
strate these time trends graphically. The
age and sex distribution of the 1991
Australian population was used as the
standard population.
Ethical approval
The project was approved by the human
research ethics committees of the Men-
zies School of Health Research and of
Charles Darwin University.
RESULTS
There were 484 cancer deaths in NT
Indigenous residents in 1991–2000.
During this period, cancer mortality
rates in the NT Indigenous population
were higher for cancers at several sites,
and lower for a small number of sites,
compared with those for the total Aus-
tralian population; mortality rate ratios
ranged from 9.4 for thyroid cancer to
0.1 for kidney cancer (Box 1). There
were no deaths from melanoma in the
Indigenous population. For most can-
cer sites, the mortality rate ratio was
higher in younger than older people for
most cancers, this difference being sta-
tistically significant for six cancers
(Box 1).
Between 1977 and 2000, cancer mor-
tality in the NT Indigenous population
1: Cancer mortality rate ratios* (NT Indigenous population compared with 
the total Australian population), by age group, 1991–2000
Site/type of cancer 0–64 years
65 years 
and over All ages†
Interaction
P-value†
Oropharynx 8.0 (5.5, 11.6) 2.0 (0.8, 4.8) — < 0.01
Oesophagus 2.9 (1.5, 5.6) 1.2 (0.5, 2.9) 1.9 (1.1, 3.2) 0.11
Stomach 1.4 (0.6, 3.0) 0.2 (0.0, 1.2)          0.7 (0.3, 1.4)      0.06
Colon and rectum 0.9 (0.5, 1.4) 0.2 (0.1, 0.6) — 0.01
Liver and gallbladder 5.5 (3.6, 8.6) 5.8 (3.9, 8.6) 5.7 (4.2, 7.6) 0.88
Pancreas 4.1 (2.7, 6.3) 1.1 (0.5, 2.2) — < 0.001
Lung 3.6 (2.9, 4.5) 1.4 (1.0, 1.9) — < 0.001
Melanoma 0.0 0.0 0.0 na
Breast 0.8 (0.5, 1.3) 0.9 (0.4, 1.8) 0.8 (0.6, 1.3) 0.86
Uterus‡ 3.4 (1.1, 10.7) 2.5 (0.8, 7.6) 2.9 (1.3, 6.4) 0.68
Cervix 8.0 (5.2, 12.4) 10.1 (5.4, 19.1) 8.6 (6.0, 12.3) 0.56
Ovary 1.0 (0.4, 2.6) 1.3 (0.5, 3.5) 1.1 (0.6, 2.2) 0.67
Prostate 0.9 (0.2, 3.6) 0.3 (0.1, 0.8) 0.4 (0.2, 0.8) 0.23
Bladder 1.5 (0.4, 6.1) 0.5 (0.1, 1.9) 0.7 (0.3, 1.9) 0.24
Kidney 0.3 (0.0, 2.2) 0.0 0.1 (0.0, 1.0) 1.00
Thyroid 12.9 (4.8, 34.7) 6.1 (1.5, 24.7) 9.4 (4.2, 21.1) 0.40
Unknown primary 3.2 (2.1, 4.7) 1.7 (1.0, 2.6) — 0.04
Non-Hodgkin’s lymphoma 1.1 (0.5, 2.2) 0.7 (0.2, 1.7) 0.9 (0.5, 1.6) 0.40
Leukaemia 1.5 (0.9, 2.5) 0.8 (0.3, 2.0) 1.2 (0.8, 1.9) 0.25
* Mortality rate ratio estimated by negative binomial regression.
† Mortality rate ratios are reported separately for age groups 0–64 and 65 years and over; the rate ratio for all 
ages combined is reported only where the P value of an interaction term testing for difference in mortality rate 
between younger and older age groups was > 0.05.
‡ Not including cervix.
na = not applicable because rate ratio was zero (no NT Indigenous deaths from this cancer in 1991–2000).
2: Change in NT Indigenous cancer mortality rates, 1977–2000
Primary site/
type of cancer
Average annual percentage 
change (95% CI)*
Percentage change 
over 24 years†
Total cases 
1977–2000
Oropharynx 9.5 (4.1, 15.1) 700 44
Oesophagus 5.6 (−1.1, 12.7) 248 22
Stomach −0.8 (−7.4, 6.3) −17 18
Colon and rectum −3.5 (−7.3, 0.6) −55 52
Liver and gallbladder 2.1 (−0.9, 5.3) 62 90
Pancreas 7.4 (2.3, 12.7) 415 43
Lung 3.0 (1.0, 5.0) 99 235
Breast (female) 4.4 (−0.5, 9.5) 168 42
Cervix −1.5 (−5.4, 2.6) −29 69
Non-Hodgkin’s lymphoma 1.0 (−5.6, 7.9) 24 20
Leukaemia 2.5 (−2.8, 8.0) 125 31
All cancers 925
* Average annual percentage change, as estimated by negative binomial regression.
† Percentage change over 24 years calculated as annual percentage change raised to the power of 23.
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increased for eight cancer sites and fell
for three; the rise was statistically signif-
icant for cancers of the oropharynx,
lung and pancreas (Boxes 2, 3 and 4).
Lung cancer was by far the commonest
registered cause of cancer death in NT
Indigenous people and mortality from
lung cancer doubled between 1977 and
2000. In contrast, lung cancer mortality
in all Australians increased by 55% in
women and fell by 26% in men over the
same period (Box 3).
The breast cancer mortality rate in
NT Indigenous people was lower than
the total Australian rate, except in
1997–2000, and showed no clear
trends (Box 4). In contrast, the NT
Indigenous mortality rate for cancer of
the cervix was much higher than the
total Australian rate, but fell in 1997–
2000 to under half the previous rate,
although the 95% confidence interval
for the annual percentage change was
wide (Box 2).
Mortality rates in the NT Indigenous
population for all smoking-related can-
cers more than doubled from 57.4 per
100 000 in 1977–1982 to 117.3 per
100 000 in 1997–2000, showing a
greater increase than mortality rates for
all non-smoking-related cancers com-
bined (Box 5). Lung cancer, which was
the cause of over half of the smoking-
related cancer deaths, alone accounted
for 21% of all NT Indigenous cancer
deaths in 1977–1981, increasing to 26%
in 1997–2000, compared with a
decrease from 21% to 19% for the total
Australian population.
DISCUSSION
Cancer mortality rates as indicators of
Indigenous people’s burden of cancer in
the NT present a mixed picture. For
several cancers mortality rates are lower
than those for the total Australian popu-
lation, while, for others, particularly
smoking-related cancers, the mortality
rates are higher, and have increased
considerably since 1977. In addition,
cancer mortality rates in NT Indigenous
people are relatively higher in younger
than in older age groups compared with
rates for the total Australian population
at the same age.
The very high mortality rates for can-
cer of the cervix are amenable to rapid
reduction through preventive Pap test
programs, with earlier diagnosis and
treatment improving survival. The fall
in cervical cancer mortality seen in
1997–2000 may be an early sign of
improvement, but longer-term data are
required to be certain of any improve-
ment trends.
For cancers with high survival rates in
the general Australian population, such
as thyroid and breast cancer, Indige-
nous mortality rates could probably be
reduced through earlier diagnosis and
improved access to effective treatment.
For other cancers with low survival,
such as lung, pancreas and liver, longer-
term improvements in mortality are
possible through preventive strategies,
such as smoking reduction and hepatitis
B vaccination programs. Ongoing mon-
itoring is important to indicate whether
any of these potential gains are being
achieved.
Higher cancer mortality rate ratios for
younger than older Indigenous people
are particularly marked for smoking-
related cancers, and probably a conse-
quence of a comparatively recent uptake
of smoking by NT Indigenous peo-
ple,9,10 and the higher levels of tobacco
consumption by Indigenous teenagers
and young adults in recent decades.11 A
“healthy survivor” effect may also play a
part if early mortality from other smok-
ing-related diseases lowers the propor-
tion of smokers, particularly heavy
smokers, who survive past 65 years of
age.
On a more positive note, Indigenous
cancer mortality is persistently low for-
cancers of the colon and rectum, kidney,
5: Smoking-related cancers 
versus other cancers, 
1977–2000
NT Indigenous mortality rates for smoking-
related cancers and other cancers, 1977–
2000. Mortality rates are age- and sex-
standardised to the 1991 Australian 
population distribution.
R
at
e 
pe
r 1
00
 
00
0
Smoking-related
cancers
Other cancers
Unknown primary
site
0
20
40
60
80
100
120
140
1997-001992-961987-911982-861977-81
3: Lung cancer, 1977–2000
Mortality rate trends for lung cancer for the 
NT Indigenous population and the total 
Australian population, by sex, 1977–2000. 
Mortality rates are age- and sex-
standardised to the 1991 Australian 
population distribution.
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1977–2000
Cancer mortality rate trends for the NT 
Indigenous population and the total 
Australian population, 1977–2000. Mortality 
rates are age- and sex-standardised to the 
1991 Australian population distribution.
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prostate and melanoma. As Indigenous
lifestyles change, mortality from some of
these cancers might increase, but this is
not yet apparent in the NT.
There are several potential sources of
inaccuracy in our findings. Some Indig-
enous people may be misclassified in
death records as non-Indigenous,
resulting in incorrectly low Indigenous
mortality rates. However, comparison
of the cancer mortality rates in the non-
Indigenous population of the NT with
those in the total Australian population
(data not shown) shows that the rates
are, if anything, only a little higher than
would be expected. Thus, any misclassi-
fication of Indigenous status is small
and with no apparent time trend. While
misclassification of cause of death might
also have affected the accuracy of our
data,12 it is unlikely that it would
account for the large differences
between Indigenous and total Austral-
ian mortality rates reported here. Indig-
enous people were included in total
Australian mortality rates when these
differences were estimated, but they
comprise only 2% of the Australian
population and their inclusion would
have minimal effects on the differences.
The increasing cancer mortality rates,
and the more pronounced differences
between NT Indigenous and total Aus-
tralian cancer mortality rates in younger
than older adults, demonstrate that can-
cer is an important and increasing
health problem for Indigenous Austral-
ians. As cancers affecting Indigenous
Australians to a greater extent than
other Australians are largely preventa-
ble, the major challenges in cancer con-
trol lie in prevention — particularly by
reducing tobacco consumption, increas-
ing the coverage of Pap smear testing
and follow-up treatment, and maintain-
ing high hepatitis B vaccination levels.2
Efforts to prevent these cancers have
been increasingly successful over several
decades for other Australians. It is high
time Indigenous Australians shared in
these successes.
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